Global Calcium Antagonists Market Research Report 2024

Calcium Antagonists Market

Calcium antagonists are a group of medications that disrupt the movement of calcium (Ca2+) through calcium channels. Calcium channel blockers are used as antihypertensive drugs, i.e., as medications to decrease blood pressure in patients with hypertension. CCBs are particularly effective against large vessel stiffness, one of the common causes of elevated systolic blood pressure in elderly patients. Calcium channel blockers are also frequently used to alter heart rate (especially from atrial fibrillation), to prevent peripheral and cerebral vasospasm, and to reduce chest pain caused by angina pectoris.

N-type, L-type, and T-type voltage-dependent calcium channels are present in the zona glomerulosa of the human adrenal gland, and CCBs can directly influence the biosynthesis of aldosterone in adrenocortical cells, with consequent impact on the clinical treatment of hypertension with these agents.

CCBs have been shown to be slightly more effective than beta blockers at lowering cardiovascular mortality, but they are associated with more side effects. Potential major risks however were mainly found to be associated with short-acting CCBs.

The global Calcium Antagonists market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Calcium Antagonists, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Calcium Antagonists.

Report Scope

The Calcium Antagonists market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Calcium Antagonists market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Calcium Antagonists manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Pfizer

Aventis

Searle

Bayer

AstraZeneca

Knoll Pharmaceuticals

Wyeth-Ayerst

Novartis

Sanofi

Baiyunshan Pharmaceutical

South China Pharmaceutical Group

Tianjin Tanabe Seiyaku

Dihydropyridine

Diltiazem

Verapamil

Others

Hypertension

Coronary Artery Disease

Arrhythmia

Ohers

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

U.A.E

Scope of Calcium Antagonists Market Report

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Calcium Antagonists manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of Calcium Antagonists in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 9: The main points and conclusions of the report.

1.1 Product Overview and Scope of Calcium Antagonists

1.2 Calcium Antagonists Segment by Type

1.2.1 Global Calcium Antagonists Market Value Comparison by Type (2024-2030)

1.2.2 Dihydropyridine

1.2.3 Diltiazem

1.2.4 Verapamil

1.2.5 Others

1.3 Calcium Antagonists Segment by Application

1.3.1 Global Calcium Antagonists Market Value by Application: (2024-2030)

1.3.2 Hypertension

1.3.3 Coronary Artery Disease

1.3.4 Arrhythmia

1.3.5 Ohers

1.4 Global Calcium Antagonists Market Size Estimates and Forecasts

1.4.1 Global Calcium Antagonists Revenue 2019-2030

1.4.2 Global Calcium Antagonists Sales 2019-2030

1.4.3 Global Calcium Antagonists Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2.1 Global Calcium Antagonists Sales Market Share by Manufacturers (2019-2024)

2.2 Global Calcium Antagonists Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Calcium Antagonists Average Price by Manufacturers (2019-2024)

2.4 Global Calcium Antagonists Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Calcium Antagonists, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Calcium Antagonists, Product Type & Application

2.7 Calcium Antagonists Market Competitive Situation and Trends

2.7.1 Calcium Antagonists Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Calcium Antagonists Players Market Share by Revenue

2.7.3 Global Calcium Antagonists Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3.1 Global Calcium Antagonists Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Calcium Antagonists Global Calcium Antagonists Sales by Region: 2019-2030

3.2.1 Global Calcium Antagonists Sales by Region: 2019-2024

3.2.2 Global Calcium Antagonists Sales by Region: 2025-2030

3.3 Global Calcium Antagonists Global Calcium Antagonists Revenue by Region: 2019-2030

3.3.1 Global Calcium Antagonists Revenue by Region: 2019-2024

3.3.2 Global Calcium Antagonists Revenue by Region: 2025-2030

3.4 North America Calcium Antagonists Market Facts & Figures by Country

3.4.1 North America Calcium Antagonists Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Calcium Antagonists Sales by Country (2019-2030)

3.4.3 North America Calcium Antagonists Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Calcium Antagonists Market Facts & Figures by Country

3.5.1 Europe Calcium Antagonists Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Calcium Antagonists Sales by Country (2019-2030)

3.5.3 Europe Calcium Antagonists Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Calcium Antagonists Market Facts & Figures by Country

3.6.1 Asia Pacific Calcium Antagonists Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Calcium Antagonists Sales by Country (2019-2030)

3.6.3 Asia Pacific Calcium Antagonists Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Calcium Antagonists Market Facts & Figures by Country

3.7.1 Latin America Calcium Antagonists Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Calcium Antagonists Sales by Country (2019-2030)

3.7.3 Latin America Calcium Antagonists Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Calcium Antagonists Market Facts & Figures by Country

3.8.1 Middle East and Africa Calcium Antagonists Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Calcium Antagonists Sales by Country (2019-2030)

3.8.3 Middle East and Africa Calcium Antagonists Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4.1 Global Calcium Antagonists Sales by Type (2019-2030)

4.1.1 Global Calcium Antagonists Sales by Type (2019-2024)

4.1.2 Global Calcium Antagonists Sales by Type (2025-2030)

4.1.3 Global Calcium Antagonists Sales Market Share by Type (2019-2030)

4.2 Global Calcium Antagonists Revenue by Type (2019-2030)

4.2.1 Global Calcium Antagonists Revenue by Type (2019-2024)

4.2.2 Global Calcium Antagonists Revenue by Type (2025-2030)

4.2.3 Global Calcium Antagonists Revenue Market Share by Type (2019-2030)

4.3 Global Calcium Antagonists Price by Type (2019-2030)

5.1 Global Calcium Antagonists Sales by Application (2019-2030)

5.1.1 Global Calcium Antagonists Sales by Application (2019-2024)

5.1.2 Global Calcium Antagonists Sales by Application (2025-2030)

5.1.3 Global Calcium Antagonists Sales Market Share by Application (2019-2030)

5.2 Global Calcium Antagonists Revenue by Application (2019-2030)

5.2.1 Global Calcium Antagonists Revenue by Application (2019-2024)

5.2.2 Global Calcium Antagonists Revenue by Application (2025-2030)

5.2.3 Global Calcium Antagonists Revenue Market Share by Application (2019-2030)

5.3 Global Calcium Antagonists Price by Application (2019-2030)

6.1 Pfizer

6.1.1 Pfizer Corporation Information

6.1.2 Pfizer Description and Business Overview

6.1.3 Pfizer Calcium Antagonists Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Pfizer Calcium Antagonists Product Portfolio

6.1.5 Pfizer Recent Developments/Updates

6.2 Aventis

6.2.1 Aventis Corporation Information

6.2.2 Aventis Description and Business Overview

6.2.3 Aventis Calcium Antagonists Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Aventis Calcium Antagonists Product Portfolio

6.2.5 Aventis Recent Developments/Updates

6.3 Searle

6.3.1 Searle Corporation Information

6.3.2 Searle Description and Business Overview

6.3.3 Searle Calcium Antagonists Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Searle Calcium Antagonists Product Portfolio

6.3.5 Searle Recent Developments/Updates

6.4 Bayer

6.4.1 Bayer Corporation Information

6.4.2 Bayer Description and Business Overview

6.4.3 Bayer Calcium Antagonists Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Bayer Calcium Antagonists Product Portfolio

6.4.5 Bayer Recent Developments/Updates

6.5 AstraZeneca

6.5.1 AstraZeneca Corporation Information

6.5.2 AstraZeneca Description and Business Overview

6.5.3 AstraZeneca Calcium Antagonists Sales, Revenue and Gross Margin (2019-2024)

6.5.4 AstraZeneca Calcium Antagonists Product Portfolio

6.5.5 AstraZeneca Recent Developments/Updates

6.6 Knoll Pharmaceuticals

6.6.1 Knoll Pharmaceuticals Corporation Information

6.6.2 Knoll Pharmaceuticals Description and Business Overview

6.6.3 Knoll Pharmaceuticals Calcium Antagonists Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Knoll Pharmaceuticals Calcium Antagonists Product Portfolio

6.6.5 Knoll Pharmaceuticals Recent Developments/Updates

6.7 Wyeth-Ayerst

6.6.1 Wyeth-Ayerst Corporation Information

6.6.2 Wyeth-Ayerst Description and Business Overview

6.6.3 Wyeth-Ayerst Calcium Antagonists Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Wyeth-Ayerst Calcium Antagonists Product Portfolio

6.7.5 Wyeth-Ayerst Recent Developments/Updates

6.8 Novartis

6.8.1 Novartis Corporation Information

6.8.2 Novartis Description and Business Overview

6.8.3 Novartis Calcium Antagonists Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Novartis Calcium Antagonists Product Portfolio

6.8.5 Novartis Recent Developments/Updates

6.9 Sanofi

6.9.1 Sanofi Corporation Information

6.9.2 Sanofi Description and Business Overview

6.9.3 Sanofi Calcium Antagonists Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Sanofi Calcium Antagonists Product Portfolio

6.9.5 Sanofi Recent Developments/Updates

6.10 Baiyunshan Pharmaceutical

6.10.1 Baiyunshan Pharmaceutical Corporation Information

6.10.2 Baiyunshan Pharmaceutical Description and Business Overview

6.10.3 Baiyunshan Pharmaceutical Calcium Antagonists Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Baiyunshan Pharmaceutical Calcium Antagonists Product Portfolio

6.10.5 Baiyunshan Pharmaceutical Recent Developments/Updates

6.11 South China Pharmaceutical Group

6.11.1 South China Pharmaceutical Group Corporation Information

6.11.2 South China Pharmaceutical Group Calcium Antagonists Description and Business Overview

6.11.3 South China Pharmaceutical Group Calcium Antagonists Sales, Revenue and Gross Margin (2019-2024)

6.11.4 South China Pharmaceutical Group Calcium Antagonists Product Portfolio

6.11.5 South China Pharmaceutical Group Recent Developments/Updates

6.12 Tianjin Tanabe Seiyaku

6.12.1 Tianjin Tanabe Seiyaku Corporation Information

6.12.2 Tianjin Tanabe Seiyaku Calcium Antagonists Description and Business Overview

6.12.3 Tianjin Tanabe Seiyaku Calcium Antagonists Sales, Revenue and Gross Margin (2019-2024)

6.12.4 Tianjin Tanabe Seiyaku Calcium Antagonists Product Portfolio

6.12.5 Tianjin Tanabe Seiyaku Recent Developments/Updates

7.1 Calcium Antagonists Industry Chain Analysis

7.2 Calcium Antagonists Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Calcium Antagonists Production Mode & Process

7.4 Calcium Antagonists Sales and Marketing

7.4.1 Calcium Antagonists Sales Channels

7.4.2 Calcium Antagonists Distributors

7.5 Calcium Antagonists Customers

8.1 Calcium Antagonists Industry Trends

8.2 Calcium Antagonists Market Drivers

8.3 Calcium Antagonists Market Challenges

8.4 Calcium Antagonists Market Restraints

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

List of Tables

    Table 1. Global Calcium Antagonists Market Value Comparison by Type (2024-2030) & (US$ Million)

    Table 2. Global Calcium Antagonists Market Value Comparison by Application (2024-2030) & (US$ Million)

    Table 3. Global Calcium Antagonists Market Competitive Situation by Manufacturers in 2023

    Table 4. Global Calcium Antagonists Sales (K Units) of Key Manufacturers (2019-2024)

    Table 5. Global Calcium Antagonists Sales Market Share by Manufacturers (2019-2024)

    Table 6. Global Calcium Antagonists Revenue (US$ Million) by Manufacturers (2019-2024)

    Table 7. Global Calcium Antagonists Revenue Share by Manufacturers (2019-2024)

    Table 8. Global Market Calcium Antagonists Average Price (USD/Unit) of Key Manufacturers (2019-2024)

    Table 9. Global Key Players of Calcium Antagonists, Industry Ranking, 2022 VS 2023 VS 2024

    Table 10. Global Key Manufacturers of Calcium Antagonists, Manufacturing Sites & Headquarters

    Table 11. Global Key Manufacturers of Calcium Antagonists, Product Type & Application

    Table 12. Global Key Manufacturers of Calcium Antagonists, Date of Enter into This Industry

    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

    Table 14. Global Calcium Antagonists by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Calcium Antagonists as of 2023)

    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

    Table 16. Global Calcium Antagonists Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

    Table 17. Global Calcium Antagonists Sales by Region (2019-2024) & (K Units)

    Table 18. Global Calcium Antagonists Sales Market Share by Region (2019-2024)

    Table 19. Global Calcium Antagonists Sales by Region (2025-2030) & (K Units)

    Table 20. Global Calcium Antagonists Sales Market Share by Region (2025-2030)

    Table 21. Global Calcium Antagonists Revenue by Region (2019-2024) & (US$ Million)

    Table 22. Global Calcium Antagonists Revenue Market Share by Region (2019-2024)

    Table 23. Global Calcium Antagonists Revenue by Region (2025-2030) & (US$ Million)

    Table 24. Global Calcium Antagonists Revenue Market Share by Region (2025-2030)

    Table 25. North America Calcium Antagonists Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

    Table 26. North America Calcium Antagonists Sales by Country (2019-2024) & (K Units)

    Table 27. North America Calcium Antagonists Sales by Country (2025-2030) & (K Units)

    Table 28. North America Calcium Antagonists Revenue by Country (2019-2024) & (US$ Million)

    Table 29. North America Calcium Antagonists Revenue by Country (2025-2030) & (US$ Million)

    Table 30. Europe Calcium Antagonists Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

    Table 31. Europe Calcium Antagonists Sales by Country (2019-2024) & (K Units)

    Table 32. Europe Calcium Antagonists Sales by Country (2025-2030) & (K Units)

    Table 33. Europe Calcium Antagonists Revenue by Country (2019-2024) & (US$ Million)

    Table 34. Europe Calcium Antagonists Revenue by Country (2025-2030) & (US$ Million)

    Table 35. Asia Pacific Calcium Antagonists Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

    Table 36. Asia Pacific Calcium Antagonists Sales by Region (2019-2024) & (K Units)

    Table 37. Asia Pacific Calcium Antagonists Sales by Region (2025-2030) & (K Units)

    Table 38. Asia Pacific Calcium Antagonists Revenue by Region (2019-2024) & (US$ Million)

    Table 39. Asia Pacific Calcium Antagonists Revenue by Region (2025-2030) & (US$ Million)

    Table 40. Latin America Calcium Antagonists Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

    Table 41. Latin America Calcium Antagonists Sales by Country (2019-2024) & (K Units)

    Table 42. Latin America Calcium Antagonists Sales by Country (2025-2030) & (K Units)

    Table 43. Latin America Calcium Antagonists Revenue by Country (2019-2024) & (US$ Million)

    Table 44. Latin America Calcium Antagonists Revenue by Country (2025-2030) & (US$ Million)

    Table 45. Middle East & Africa Calcium Antagonists Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

    Table 46. Middle East & Africa Calcium Antagonists Sales by Country (2019-2024) & (K Units)

    Table 47. Middle East & Africa Calcium Antagonists Sales by Country (2025-2030) & (K Units)

    Table 48. Middle East & Africa Calcium Antagonists Revenue by Country (2019-2024) & (US$ Million)

    Table 49. Middle East & Africa Calcium Antagonists Revenue by Country (2025-2030) & (US$ Million)

    Table 50. Global Calcium Antagonists Sales (K Units) by Type (2019-2024)

    Table 51. Global Calcium Antagonists Sales (K Units) by Type (2025-2030)

    Table 52. Global Calcium Antagonists Sales Market Share by Type (2019-2024)

    Table 53. Global Calcium Antagonists Sales Market Share by Type (2025-2030)

    Table 54. Global Calcium Antagonists Revenue (US$ Million) by Type (2019-2024)

    Table 55. Global Calcium Antagonists Revenue (US$ Million) by Type (2025-2030)

    Table 56. Global Calcium Antagonists Revenue Market Share by Type (2019-2024)

    Table 57. Global Calcium Antagonists Revenue Market Share by Type (2025-2030)

    Table 58. Global Calcium Antagonists Price (USD/Unit) by Type (2019-2024)

    Table 59. Global Calcium Antagonists Price (USD/Unit) by Type (2025-2030)

    Table 60. Global Calcium Antagonists Sales (K Units) by Application (2019-2024)

    Table 61. Global Calcium Antagonists Sales (K Units) by Application (2025-2030)

    Table 62. Global Calcium Antagonists Sales Market Share by Application (2019-2024)

    Table 63. Global Calcium Antagonists Sales Market Share by Application (2025-2030)

    Table 64. Global Calcium Antagonists Revenue (US$ Million) by Application (2019-2024)

    Table 65. Global Calcium Antagonists Revenue (US$ Million) by Application (2025-2030)

    Table 66. Global Calcium Antagonists Revenue Market Share by Application (2019-2024)

    Table 67. Global Calcium Antagonists Revenue Market Share by Application (2025-2030)

    Table 68. Global Calcium Antagonists Price (USD/Unit) by Application (2019-2024)

    Table 69. Global Calcium Antagonists Price (USD/Unit) by Application (2025-2030)

    Table 70. Pfizer Corporation Information

    Table 71. Pfizer Description and Business Overview

    Table 72. Pfizer Calcium Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

    Table 73. Pfizer Calcium Antagonists Product

    Table 74. Pfizer Recent Developments/Updates

    Table 75. Aventis Corporation Information

    Table 76. Aventis Description and Business Overview

    Table 77. Aventis Calcium Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

    Table 78. Aventis Calcium Antagonists Product

    Table 79. Aventis Recent Developments/Updates

    Table 80. Searle Corporation Information

    Table 81. Searle Description and Business Overview

    Table 82. Searle Calcium Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

    Table 83. Searle Calcium Antagonists Product

    Table 84. Searle Recent Developments/Updates

    Table 85. Bayer Corporation Information

    Table 86. Bayer Description and Business Overview

    Table 87. Bayer Calcium Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

    Table 88. Bayer Calcium Antagonists Product

    Table 89. Bayer Recent Developments/Updates

    Table 90. AstraZeneca Corporation Information

    Table 91. AstraZeneca Description and Business Overview

    Table 92. AstraZeneca Calcium Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

    Table 93. AstraZeneca Calcium Antagonists Product

    Table 94. AstraZeneca Recent Developments/Updates

    Table 95. Knoll Pharmaceuticals Corporation Information

    Table 96. Knoll Pharmaceuticals Description and Business Overview

    Table 97. Knoll Pharmaceuticals Calcium Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

    Table 98. Knoll Pharmaceuticals Calcium Antagonists Product

    Table 99. Knoll Pharmaceuticals Recent Developments/Updates

    Table 100. Wyeth-Ayerst Corporation Information

    Table 101. Wyeth-Ayerst Description and Business Overview

    Table 102. Wyeth-Ayerst Calcium Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

    Table 103. Wyeth-Ayerst Calcium Antagonists Product

    Table 104. Wyeth-Ayerst Recent Developments/Updates

    Table 105. Novartis Corporation Information

    Table 106. Novartis Description and Business Overview

    Table 107. Novartis Calcium Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

    Table 108. Novartis Calcium Antagonists Product

    Table 109. Novartis Recent Developments/Updates

    Table 110. Sanofi Corporation Information

    Table 111. Sanofi Description and Business Overview

    Table 112. Sanofi Calcium Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

    Table 113. Sanofi Calcium Antagonists Product

    Table 114. Sanofi Recent Developments/Updates

    Table 115. Baiyunshan Pharmaceutical Corporation Information

    Table 116. Baiyunshan Pharmaceutical Description and Business Overview

    Table 117. Baiyunshan Pharmaceutical Calcium Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

    Table 118. Baiyunshan Pharmaceutical Calcium Antagonists Product

    Table 119. Baiyunshan Pharmaceutical Recent Developments/Updates

    Table 120. South China Pharmaceutical Group Corporation Information

    Table 121. South China Pharmaceutical Group Description and Business Overview

    Table 122. South China Pharmaceutical Group Calcium Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

    Table 123. South China Pharmaceutical Group Calcium Antagonists Product

    Table 124. South China Pharmaceutical Group Recent Developments/Updates

    Table 125. Tianjin Tanabe Seiyaku Corporation Information

    Table 126. Tianjin Tanabe Seiyaku Description and Business Overview

    Table 127. Tianjin Tanabe Seiyaku Calcium Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

    Table 128. Tianjin Tanabe Seiyaku Calcium Antagonists Product

    Table 129. Tianjin Tanabe Seiyaku Recent Developments/Updates

    Table 130. Key Raw Materials Lists

    Table 131. Raw Materials Key Suppliers Lists

    Table 132. Calcium Antagonists Distributors List

    Table 133. Calcium Antagonists Customers List

    Table 134. Calcium Antagonists Market Trends

    Table 135. Calcium Antagonists Market Drivers

    Table 136. Calcium Antagonists Market Challenges

    Table 137. Calcium Antagonists Market Restraints

    Table 138. Research Programs/Design for This Report

    Table 139. Key Data Information from Secondary Sources

    Table 140. Key Data Information from Primary Sources

List of Figures

    Figure 1. Product Picture of Calcium Antagonists

    Figure 2. Global Calcium Antagonists Market Value Comparison by Type (2024-2030) & (US$ Million)

    Figure 3. Global Calcium Antagonists Market Share by Type in 2023 & 2030

    Figure 4. Dihydropyridine Product Picture

    Figure 5. Diltiazem Product Picture

    Figure 6. Verapamil Product Picture

    Figure 7. Others Product Picture

    Figure 8. Global Calcium Antagonists Market Value Comparison by Application (2024-2030) & (US$ Million)

    Figure 9. Global Calcium Antagonists Market Share by Application in 2023 & 2030

    Figure 10. Hypertension

    Figure 11. Coronary Artery Disease

    Figure 12. Arrhythmia

    Figure 13. Ohers

    Figure 14. Global Calcium Antagonists Revenue, (US$ Million), 2019 VS 2023 VS 2030

    Figure 15. Global Calcium Antagonists Market Size (2019-2030) & (US$ Million)

    Figure 16. Global Calcium Antagonists Sales (2019-2030) & (K Units)

    Figure 17. Global Calcium Antagonists Average Price (USD/Unit) & (2019-2030)

    Figure 18. Calcium Antagonists Report Years Considered

    Figure 19. Calcium Antagonists Sales Share by Manufacturers in 2023

    Figure 20. Global Calcium Antagonists Revenue Share by Manufacturers in 2023

    Figure 21. The Global 5 and 10 Largest Calcium Antagonists Players: Market Share by Revenue in 2023

    Figure 22. Calcium Antagonists Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

    Figure 23. Global Calcium Antagonists Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

    Figure 24. North America Calcium Antagonists Sales Market Share by Country (2019-2030)

    Figure 25. North America Calcium Antagonists Revenue Market Share by Country (2019-2030)

    Figure 26. U.S. Calcium Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)

    Figure 27. Canada Calcium Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)

    Figure 28. Europe Calcium Antagonists Sales Market Share by Country (2019-2030)

    Figure 29. Europe Calcium Antagonists Revenue Market Share by Country (2019-2030)

    Figure 30. Germany Calcium Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)

    Figure 31. France Calcium Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)

    Figure 32. U.K. Calcium Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)

    Figure 33. Italy Calcium Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)

    Figure 34. Russia Calcium Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)

    Figure 35. Asia Pacific Calcium Antagonists Sales Market Share by Region (2019-2030)

    Figure 36. Asia Pacific Calcium Antagonists Revenue Market Share by Region (2019-2030)

    Figure 37. China Calcium Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)

    Figure 38. Japan Calcium Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)

    Figure 39. South Korea Calcium Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)

    Figure 40. India Calcium Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)

    Figure 41. Australia Calcium Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)

    Figure 42. Taiwan Calcium Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)

    Figure 43. Indonesia Calcium Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)

    Figure 44. Thailand Calcium Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)

    Figure 45. Malaysia Calcium Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)

    Figure 46. Philippines Calcium Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)

    Figure 47. Latin America Calcium Antagonists Sales Market Share by Country (2019-2030)

    Figure 48. Latin America Calcium Antagonists Revenue Market Share by Country (2019-2030)

    Figure 49. Mexico Calcium Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)

    Figure 50. Brazil Calcium Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)

    Figure 51. Argentina Calcium Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)

    Figure 52. Middle East & Africa Calcium Antagonists Sales Market Share by Country (2019-2030)

    Figure 53. Middle East & Africa Calcium Antagonists Revenue Market Share by Country (2019-2030)

    Figure 54. Turkey Calcium Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)

    Figure 55. Saudi Arabia Calcium Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)

    Figure 56. U.A.E Calcium Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)

    Figure 57. Global Sales Market Share of Calcium Antagonists by Type (2019-2030)

    Figure 58. Global Revenue Market Share of Calcium Antagonists by Type (2019-2030)

    Figure 59. Global Calcium Antagonists Price (USD/Unit) by Type (2019-2030)

    Figure 60. Global Sales Market Share of Calcium Antagonists by Application (2019-2030)

    Figure 61. Global Revenue Market Share of Calcium Antagonists by Application (2019-2030)

    Figure 62. Global Calcium Antagonists Price (USD/Unit) by Application (2019-2030)

    Figure 63. Calcium Antagonists Value Chain

    Figure 64. Calcium Antagonists Production Process

    Figure 65. Channels of Distribution (Direct Vs Distribution)

    Figure 66. Distributors Profiles

    Figure 67. Bottom-up and Top-down Approaches for This Report

    Figure 68. Data Triangulation

    Figure 69. Key Executives Interviewed